Beryllium granuloma

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Beryllium granuloma
File:Granuloma.jpg
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Cough, shortness of breath, fatigue
Complications	Chronic beryllium disease, pulmonary fibrosis
Onset	Variable, often years after exposure
Duration	Chronic
Types	N/A
Causes	Exposure to beryllium
Risks	Occupational exposure in industries such as aerospace, nuclear power, and electronics
Diagnosis	Chest X-ray, CT scan, lung biopsy, beryllium lymphocyte proliferation test
Differential diagnosis	Sarcoidosis, tuberculosis, hypersensitivity pneumonitis
Prevention	Avoidance of beryllium exposure, use of protective equipment
Treatment	Corticosteroids, immunosuppressive therapy
Medication	N/A
Prognosis	Variable, can lead to chronic lung disease
Frequency	Rare, primarily in occupational settings
Deaths	N/A

File:Granuloma.jpg

Granuloma.jpg

Beryllium granuloma is a type of granuloma that forms in response to exposure to beryllium, a chemical element with the symbol Be and atomic number 4. This condition is a manifestation of berylliosis, also known as chronic beryllium disease (CBD), which is a chronic allergic-type lung response and chronic lung disease caused by exposure to beryllium and its compounds.

Pathophysiology

Beryllium granulomas are formed as a result of the body's immune response to beryllium particles. When beryllium is inhaled, it can be deposited in the lungs and other tissues. The immune system recognizes beryllium as a foreign substance and mounts an immune response. This involves the activation of T cells, which release cytokines that attract other immune cells to the site of beryllium deposition. These immune cells form a granuloma, which is a small area of inflammation.

Clinical Presentation

Patients with beryllium granulomas may present with symptoms similar to those of other granulomatous diseases, such as sarcoidosis. Common symptoms include:

• Cough
• Shortness of breath
• Chest pain
• Fatigue

Diagnosis

The diagnosis of beryllium granuloma typically involves a combination of clinical evaluation, imaging studies, and laboratory tests. Key diagnostic tools include:

• Chest X-ray or CT scan to identify granulomas in the lungs.
• Beryllium lymphocyte proliferation test (BeLPT) to detect beryllium sensitivity.
• Biopsy of affected tissue to confirm the presence of granulomas and to rule out other causes.

Treatment

There is no cure for beryllium granuloma, but treatment focuses on managing symptoms and preventing further exposure to beryllium. Treatment options may include:

• Corticosteroids to reduce inflammation.
• Immunosuppressive drugs in severe cases.
• Avoidance of further beryllium exposure to prevent disease progression.

Prognosis

The prognosis for individuals with beryllium granuloma varies. Some individuals may experience mild symptoms and stable disease, while others may develop progressive lung disease leading to significant impairment.

Prevention

Preventing beryllium granuloma involves minimizing exposure to beryllium, particularly in occupational settings. This can be achieved through:

• Use of protective equipment.
• Implementation of safety protocols.
• Regular monitoring of beryllium levels in the workplace.

See also

• Berylliosis
• Granuloma
• Occupational lung disease
• Sarcoidosis